Difference between revisions of "HAEM4:Myelodysplastic Syndromes (MDS)"
Bailey.Glen (talk | contribs) (Created page with "{{Under Construction}} ==Primary Author(s)*== Put your text here __TOC__ ==Graphical Data Links== '''MDS, MDS/MPN and MPN Tables''' - A comprehensive list of copy number a...") |
Bailey.Glen (talk | contribs) |
||
| Line 19: | Line 19: | ||
==WHO Classification Pages (Includes Links to Content)== | ==WHO Classification Pages (Includes Links to Content)== | ||
| − | *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] | + | *[[HAEM4:Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] |
| − | *[[Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]] | + | *[[HAEM4:Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]] |
| − | *[[Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia|MDS with Ring Sideroblasts and Multilineage Dysplasia]] | + | *[[HAEM4:Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia|MDS with Ring Sideroblasts and Multilineage Dysplasia]] |
| − | *[[Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia|MDS with Multilineage Dysplasia]] | + | *[[HAEM4:Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia|MDS with Multilineage Dysplasia]] |
| − | *[[Myelodysplastic | + | *[[HAEM5:Myelodysplastic neoplasm with increased blasts|MDS with Excess Blasts]] |
| − | *[[Myelodysplastic | + | *[[HAEM5:Myelodysplastic neoplasm with low blasts and 5q deletion|MSD with Isolated del(5q)]] |
| − | *[[Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]] | + | *[[HAEM4:Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]] |
| − | *[[Refractory Cytopenia of Childhood]] | + | *[[HAEM4:Refractory Cytopenia of Childhood]] |
==Other Related Pages (Includes Links to Content)== | ==Other Related Pages (Includes Links to Content)== | ||
Latest revision as of 16:23, 4 December 2023
 | This page is under construction |
Primary Author(s)*
Put your text here
Graphical Data Links
MDS, MDS/MPN and MPN Tables - A comprehensive list of copy number alterations and CN-LOH detectable by CMA testing with strong diagnostic, prognostic and treatment implications in MDS, MDS/MPN and MPN. Tables derived from Kanagal-Shawanna et al., 2018 [PMID 30377088] with permission from Cancer Genetics. See MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alterations Detected by Chromosomal Microarray.
Put your graphics here
General Disease Overview / Description of Cancer Category
Put your text here
WHO Classification Pages (Includes Links to Content)
- MDS with Single Lineage Dysplasia
- MDS with Ring Sideroblasts (MDS-RS)
- MDS with Ring Sideroblasts and Multilineage Dysplasia
- MDS with Multilineage Dysplasia
- MDS with Excess Blasts
- MSD with Isolated del(5q)
- MDS, Unclassifiable
- HAEM4:Refractory Cytopenia of Childhood
Other Related Pages (Includes Links to Content)
Put your text here (use link icon at top of page)
Additional Information
Put your text here
References
(use "Cite" icon at top of page)
EXAMPLE Book
- Arber DA, et al., (2017). Acute myeloid leukaemia with recurrent genetic abnormalities, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, and Siebert R, Editors. IARC Press: Lyon, France, p129-171.
Notes
*Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.
*The hierarchical tumour classification structure displayed on this page is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.